Experience the breathtaking Blood Moon Eclipse of 2025. This video provides an in-depth look at this celestial phenomenon, discussing its significance, viewing locations, and optimal times for ...

Solar eclipses occur when the moon gets between Earth and the sun. This causes the moon to cast a shadow onto Earth. A solar eclipse can only take place at the phase of new moon, but different factors ...

Chris Evans and Alba Baptista welcomed their first child together on Oct. 27, 2025. The “Captain America” star and the ...

David Chase is going from the New Jersey Mafia to the inner workings of the CIA. Chase, creator of “The Sopranos,” is ...

TIOBE Index for October 2025: Top 10 Most Popular Programming Languages Your email has been sent The October TIOBE Programming Community Index brought a few quiet but meaningful shifts. Python remains ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...

(RTTNews) - Northrop Grumman Corp. (NOC), Thursday announced that it has committed $50 million to Firefly Aerospace to accelerate production of their jointly developed medium class launch vehicle, ...

CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...

Tonight, a total lunar eclipse is coming to Earth for the first time since 2022. On the night of March 13-14, 2025, North America and South America will get a great view of all phases of what is ...

First patient enrolled in ECLIPSE 1 Phase 3 clinical trial evaluating combination of tobevibart and elebsiran for chronic suppressive treatment ECLIPSE program designed to enable regulatory ...

SAN FRANCISCO--(BUSINESS WIRE)-- Vir Biotechnology, Inc. (VIR) today announced the enrollment of the first patient in its Phase 3 ECLIPSE registrational program. The ECLIPSE registrational program is ...